Skip to content

Clinical trials

Lymphoma, B-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Country / region: United States Clear all

371 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20034
20045
20058
200612
200710
20088
200910
20109
201112
20128
201314
20149
201512
201616
201721
201819
201921
202022
202128
202229
202330
202416
202515
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed143
Recruiting69
Terminated65
Active, not recruiting60
Withdrawn16
Unknown status7
Not yet recruiting6
Suspended2
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
M.D. Anderson Cancer Center19
Fred Hutchinson Cancer Center11
Mayo Clinic9
Medical College of Wisconsin8
Memorial Sloan Kettering Cancer Center8
Seagen Inc.8
AstraZeneca7
Novartis Pharmaceuticals7
Pharmacyclics LLC.7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell371
Lymphoma, Non-Hodgkin135
Lymphoma, Large B-Cell, Diffuse110
Lymphoma106
Lymphoma, Follicular94
Leukemia, Lymphocytic, Chronic, B-Cell78
Lymphoma, Mantle-Cell77
Lymphoma, B-Cell, Marginal Zone51
Burkitt Lymphoma44
Recurrence43

Trials

Showing 1 to 25 of 371. Each trial links to its page on Pharma Observatory.

271 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.